CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 

Moderna Inc 's Leverage Ratio

MRNA's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to repayements of liabilities of -23.74% Moderna Inc improved Leverage Ratio in forth quarter 2023 to 0.33, below the company's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the forth quarter 2023, 13 other companies have achieved lower Leverage Ratio than Moderna Inc in the IV Quarter 2023. While Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 251, from total ranking in the third quarter 2023 at 923 .

Explain Leverage Ratio?
Who are MRNA Customers?
What are MRNA´s Total Liabilities?


MRNA Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -27.55 % -25.22 % -5.76 % 10.47 % 35.19 %
Y / Y Total Liabilities Change -32.12 % -25.66 % -38.76 % -50.05 % -36 %
Leverage Ratio MRQ 0.33 0.45 0.29 0.28 0.35
MRNA's Total Ranking # 251 # 923 # 727 # 693 # 355
Seq. Equity Change 2.97 % -20.61 % -10.15 % -1.36 % 6.29 %
Seq. Total Liabilities Change -23.74 % 21.48 % -6.21 % -21.87 % -16.48 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 14
Healthcare Sector # 82
Overall Market # 251


Leverage Ratio Statistics
High Average Low
216.5 9.88 0.19
(Dec 31 2011)   (Jun 30 2020)




Financial Statements
Moderna Inc 's Equity $ 13,854 Millions Visit MRNA's Balance sheet
Moderna Inc 's Total Liabilities $ 4,572 Millions Visit MRNA's Balance sheet
Source of MRNA's Sales Visit MRNA's Sales by Geography


Cumulative Moderna Inc 's Leverage Ratio

MRNA's Leverage Ratio for the trailling 12 Months

MRNA Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -27.55 % -25.22 % -5.76 % 10.47 % 35.19 %
Y / Y Total Liabilities TTM Growth -32.12 % -25.66 % -38.76 % -50.05 % -36 %
Leverage Ratio TTM 0.33 0.34 0.34 0.38 0.46
Total Ranking TTM # 204 # 841 # 4 # 5 # 436
Seq. Equity TTM Growth 2.97 % -20.61 % -10.15 % -1.36 % 6.29 %
Seq. Total Liabilities TTM Growth -23.74 % 21.48 % -6.21 % -21.87 % -16.48 %


On the trailing twelve months basis Due to repayements of liabilities of -23.74% Moderna Inc decreased Leverage Ratio in the 12 months ending in IV Quarter 2023 to 0.33, below the company's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 11, during the past 12 months, other companies have achieved lower Leverage Ratio than Moderna Inc . While Leverage Ratio total ranking has improved so far to 204, from total ranking in previous 12 month period at 841.

Explain Leverage Ratio?
Who are MRNA Customers?
What are MRNA´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 12
Healthcare Sector # 78
Within the Market # 204


trailing twelve months Leverage Ratio Statistics
High Average Low
5.69 1.09 0.22
(Mar 31 2018)   (Jun 30 2020)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
Coeptis Therapeutics Holdings Inc   0.85 $ 3.658  Millions$ 4.314  Millions
Biogen Inc   0.81 $ 12,045.400  Millions$ 14,799.400  Millions
Elevation Oncology inc   0.63 $ 34.282  Millions$ 54.809  Millions
Vaxart Inc   0.59 $ 34.025  Millions$ 57.805  Millions
Vericel Corporation  0.57 $ 127.705  Millions$ 225.952  Millions
C4 Therapeutics Inc   0.53 $ 130.337  Millions$ 246.114  Millions
Immunocore Holdings Plc  0.52 $ 192.137  Millions$ 368.843  Millions
Prime Medicine Inc   0.46 $ 60.780  Millions$ 133.071  Millions
Neurocrine Biosciences Inc   0.46 $ 1,019.400  Millions$ 2,232.000  Millions
Qiagen N v   0.44 $ 1,692.857  Millions$ 3,807.764  Millions
Editas Medicine Inc   0.43 $ 150.056  Millions$ 349.097  Millions
Recursion Pharmaceuticals Inc   0.41 $ 190.263  Millions$ 463.436  Millions
Sophia Genetics Sa  0.36 $ 54.714  Millions$ 151.442  Millions
Black Diamond Therapeutics Inc   0.36 $ 41.831  Millions$ 116.736  Millions
Passage Bio inc   0.35 $ 39.262  Millions$ 111.283  Millions
Tarsus Pharmaceuticals Inc   0.35 $ 68.503  Millions$ 196.988  Millions
Moderna Inc   0.33 $ 4,572.000  Millions$ 13,854.000  Millions
Scholar Rock Holding Corp  0.33 $ 74.017  Millions$ 225.218  Millions
Iovance Biotherapeutics Inc   0.32 $ 187.961  Millions$ 584.613  Millions
Exelixis Inc   0.30 $ 678.445  Millions$ 2,263.912  Millions
Adverum Biotechnologies Inc   0.30 $ 24.914  Millions$ 83.469  Millions
Bio techne Corp  0.30 $ 582.231  Millions$ 1,963.559  Millions
Dbv Technologies S a   0.27 $ 37.696  Millions$ 140.187  Millions
Replimune Group Inc   0.26 $ 111.393  Millions$ 421.537  Millions
Allogene Therapeutics inc   0.25 $ 130.604  Millions$ 512.233  Millions
Twist Bioscience Corporation  0.24 $ 142.773  Millions$ 590.042  Millions
Vir Biotechnology Inc   0.21 $ 328.824  Millions$ 1,590.236  Millions
Anavex Life Sciences Corp   0.18 $ 24.073  Millions$ 135.575  Millions
Caribou Biosciences Inc   0.17 $ 63.808  Millions$ 368.401  Millions
Voyager Therapeutics Inc   0.17 $ 39.721  Millions$ 236.320  Millions

Date modified: 2024-02-24T15:12:42+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com